Revvity to Present at Upcoming Investor Conferences

Go back to Revvity to Present at Upcoming Investor Conferences

Buy this stock as investor China concerns 'are overblown': UBS

May 2, 2025 11:00 PM EDT

UBS upgraded Revvity (NYSE: RVTY) to Buy from Neutral in a note this week, arguing that the diagnostics and life sciences company is poised to outperform peers, despite investor concerns about its exposure to China.

We're upgrading Revvity (RVTY) to Buy from Neutral with a view that its growth algorithm could be upside differentiated vs peers', UBS analysts wrote.

The firm cited... More